Hall Laurie J Trustee Organon & Co. Transaction History

Hall Laurie J Trustee

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	SELL	$16.59 - $23.77 $6,121 - $8,771	-369 Reduced 19.23%	1,550 $27,000
Q2 2023 Jul 14, 2023	SELL	$19.27 - $24.63 $1,156 - $1,477	-60 Reduced 3.03%	1,919 $40,000
Q3 2022 Oct 11, 2022	SELL	$23.4 - $34.25 $936 - $1,370	-40 Reduced 1.98%	1,979 $47,000
Q2 2022 Jul 06, 2022	SELL	$31.66 - $38.9 $7,503 - $9,219	-237 Reduced 10.51%	2,019 $68,000
Q1 2022 Apr 06, 2022	SELL	$30.45 - $39.36 $7,764 - $10,036	-255 Reduced 10.16%	2,256 $78,000
Q4 2021 Jan 05, 2022	SELL	$28.67 - $37.13 $630 - $816	-22 Reduced 0.87%	2,511 $76,000
Q3 2021 Oct 04, 2021	SELL	$28.63 - $35.64 $10,135 - $12,616	-354 Reduced 12.26%	2,533 $82,000
Q2 2021 Jul 07, 2021	BUY	$28.45 - $38.0 $82,135 - $109,706	2,887 New	2,887 $87,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.